Charles Schwab’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-426,698
| Closed | -$8.05M | – | 3214 |
|
|
2019
Q3 | $8.05M | Buy |
426,698
+1,476
| +0.3% | +$27.8K | ﹤0.01% | 1724 |
|
|
2019
Q2 | $5.01M | Buy |
425,222
+43,849
| +11% | +$516K | ﹤0.01% | 1970 |
|
|
2019
Q1 | $5.21M | Buy |
381,373
+56,183
| +17% | +$767K | ﹤0.01% | 1963 |
|
|
2018
Q4 | $3.33M | Sell |
325,190
-2,566
| -0.8% | -$26.3K | ﹤0.01% | 2121 |
|
|
2018
Q3 | $5.46M | Buy |
327,756
+10,674
| +3% | +$178K | ﹤0.01% | 2001 |
|
|
2018
Q2 | $5.01M | Buy |
317,082
+18,415
| +6% | +$291K | ﹤0.01% | 1998 |
|
|
2018
Q1 | $3.79M | Sell |
298,667
-9,583
| -3% | -$122K | ﹤0.01% | 2078 |
|
|
2017
Q4 | $3.53M | Buy |
308,250
+47,816
| +18% | +$548K | ﹤0.01% | 2091 |
|
|
2017
Q3 | $3.19M | Buy |
260,434
+64,988
| +33% | +$796K | ﹤0.01% | 2095 |
|
|
2017
Q2 | $2.24M | Sell |
195,446
-13,827
| -7% | -$158K | ﹤0.01% | 2185 |
|
|
2017
Q1 | $4.35M | Buy |
209,273
+38,123
| +22% | +$793K | ﹤0.01% | 1836 |
|
|
2016
Q4 | $3.56M | Buy |
171,150
+5,160
| +3% | +$107K | ﹤0.01% | 1917 |
|
|
2016
Q3 | $5.44M | Buy |
165,990
+7,932
| +5% | +$260K | 0.01% | 1596 |
|
|
2016
Q2 | $3.95M | Buy |
158,058
+68,610
| +77% | +$1.71M | ﹤0.01% | 1710 |
|
|
2016
Q1 | $2.19M | Buy |
89,448
+1,900
| +2% | +$46.5K | ﹤0.01% | 2004 |
|
|
2015
Q4 | $2.89M | Buy |
87,548
+15,616
| +22% | +$516K | ﹤0.01% | 1878 |
|
|
2015
Q3 | $2.36M | Buy |
71,932
+42,186
| +142% | +$1.38M | ﹤0.01% | 1972 |
|
|
2015
Q2 | $1.58M | Buy |
29,746
+13,046
| +78% | +$691K | ﹤0.01% | 2207 |
|
|
2015
Q1 | $482K | Buy |
16,700
+5,000
| +43% | +$144K | ﹤0.01% | 2639 |
|
|
2014
Q4 | $341K | Hold |
11,700
| – | – | ﹤0.01% | 2792 |
|
|
2014
Q3 | $149K | Hold |
11,700
| – | – | ﹤0.01% | 3012 |
|
|
2014
Q2 | $235K | Buy |
+11,700
| New | +$235K | ﹤0.01% | 2949 |
|